Member Info for Kingping25

Vlad has said if results are positive funding will not be a problem and he needs 200m for phase 2 trials. This could be with hundreds of millions if those results are a success. Why is this so low?? Have a missed something

This is so undervalued

Good scientific interview

The elephant in the room re finance was not addressed but I think his plans reflect that of a business expanding and expansion requires finance. I think a jv on cbr is on the cards with upfront funds to press ahead on cart and cdx and a carry on ind and phase 1 trials for CBR.

Scary but nervous / exciting times ahead.

Share price at the moment is awful and very sobering. I think the right partner will change the way the company is viewed as it was when we all thought Eli Lilly was involved a few years back.

Keep re reading the section

“We are diligently pursuing non dilutive finance options to support these initiatives”

He will not want to give away CAR-T

But his plan was always to partner up on cbr and cdx.

We are awaiting start date of trials

We know they only have money till oct 24

Awaiting the plan regarding non dilutive funding. This is a licence deal or jv

Uncertainty is the key to the low sp. Come on vlad - get a plausible plan in place and tell the markets and this will fly.

Also the stage of AML for car T has to be at a certain stage for success of car t treatment to be successful so this must be a big task to ensure success. Please factor that into last message. I’m genuinely interested by peoples thoughts on all this

What’s people thoughts on following

No of patients for a p1 trial?

Time to assess / screen find potential candidates for success of these trials?

Time for patients to decide if they want to proceed?

Aligning doctor / hospital / university for trial?

Seems a mamouth task

No updates here from company are very strange. 3/4 months now. He has stopped responding to me as well. I reckon nda agreements have been signed and partnership arrangement is being discussed on car t with a full carry with upfront payment to advance other products. He got a huge bashing from shareholders from last raise and I think wants something more sustainable for the next few years. Time will tell

Ok we know that there needs to be a month in between treatments under fda approvals. So let’s work on basis they are trying to find 3/4 suitable candidates, hospital setting, team Tom monitor etc. finding the right patients must take about till now.

Update should be anytime

Look no one on here is a short trader or wants anything other than this company to perform. Look at the volume of shares per day. It’s non existent atm. News of trials will awake the share price performance and this will rise very fast.

Some people bought here at 5p plus and I personally think this will go back to 4p (50 mill market cap) very soon

My correspondence with him. Dhub has verified it

This

Vladik own words

“I’m certain of a breakthrough soon”

It’s just a matter of time people. I believe in the work they are doing and through will fly to eqv of 50 million cap when car t news is released.

We had news on Jan 23 and then this went flat whilst awaiting for new. This seems to following the same pattern. Check out the graph on Google.

At 50 million market cap this is 3.8p a share and I’m convinced this will what will be achieved during trials etc and buying power returning. We only have 3 months at this level as activity will start July onwards. He wants data for conference end of yr

I honestly think there will be a grant soon which will surprise the market on cbr, a potential licience or partnership on cdx and news of car t trials. This price is short lived at it will be 3p plus with 3 /4 months. Volumes per day at the moment reflect on avg less than. 1% of the shares in issue which is what happened about a yr ago. This has proven that is can rise by big amounts when it’s wakes up.

2.2 before news. News will take this to 3p and it will hover. Then we have news of grants, jv and licences and updates on clinical trials which will make this then fly. This price is a gift. I can not afford any more but I hold 14.3m shares and this is what I think. Good luck everyone

I’m so jealous that people get to have this entry level. I’m balls deep in the company with an avg 2.4p 🙁. It’s so depressing watching this drop. I can,t get my head around why anyone would sell at this price.

What do you think this will realistically go back up to on clinical dates and news by end of April with a time frame set out. Honest opinions I’m Interested in hearing

Let’s not forget that the people that have them 3.5m at 2p are currently sitting on a 15% loss. This will change Q4 2024 so great time to top up but I have no more avaliable funds so I’m just holding and waiting. Crap but the way it is .